| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/13/2001 | EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105141A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 06/13/2001 | EP1105100A1 Alginate capsules for use in the treatment of brain tumour |
| 06/13/2001 | EP1067968A4 Methods for evaluating a compound for its effect on skin |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | DE19958680A1 cDNA-Sequenzen von zwei Interaktoren FANCIP4 und FANCIP5 der Fanconi-Anämie-Pr oteine der Komplementationsgruppen A und C cDNA sequences of two interactors FANCIP4 and FANCIP5 the Fanconi anemia-Pr oteine the complementation groups A and C |
| 06/13/2001 | DE19957838A1 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden Gene therapy of HIV-infected individuals by expression of membrane-anchored gp41 peptides |
| 06/13/2001 | DE19957689A1 Proteaseresistenter Tumorsuppressor p14(ARF) Protease-resistant tumor suppressor p14 (ARF) |
| 06/13/2001 | DE19956763A1 Reducing interaction of adenoviral vectors with blood cells, useful for ex vivo gene therapy, by mutating the fiber-encoding gene in vectors or helper constructs, reduces toxicity |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299407A Vascular endothelial growth factor 2 |
| 06/13/2001 | CN1299369A Plasminogen-related gene B polypeptides |
| 06/13/2001 | CN1299272A Method and device for modulating the immune response |
| 06/13/2001 | CN1299234A Method and compounds for the genetic treatment of hyperlipidemia |
| 06/13/2001 | CN1298947A Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis inhibitor and its construction method |
| 06/12/2001 | US6245904 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245566 Human embryonic germ cell line and methods of use |
| 06/12/2001 | US6245565 Recombinase Mediated DNA modifications |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245543 Mutated herpes simplex virus type 1 thymidine kinases and uses thereof |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245512 Promoter for VEGF receptor |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040494A1 Drug inducible system and use thereof |
| 06/07/2001 | WO2001040488A1 Increased transgene expression in retroviral vectors having scaffold attachment region |
| 06/07/2001 | WO2001040477A1 Transposase and method of gene modification |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040463A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality |
| 06/07/2001 | WO2001040461A2 Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040455A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040313A2 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040301A2 A gene, disrupted in schizophrenia |
| 06/07/2001 | WO2001040300A2 Protease resistant tumor suppressor p14(arf) |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040272A2 In situ bioreactors and methods of use thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040258A2 Educational kit and method using tumor necrosis factor-stimulated gene and protein |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040247A1 Interleukin-1 homologue, mat il-1h4 |
| 06/07/2001 | WO2001039802A1 Chimeric flavivirus vaccines |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | WO2001039789A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001012213A3 Ttp-related zinc finger domains and methods of use |
| 06/07/2001 | WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000078960A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2000040692A9 Methods and compositions for delivering nucleic acids |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO1999063071A3 Method for triggering apoptosis in cells |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394016A1 Novel endoplasmic localization proteins,therapeutic agents for glycoprotein aberration disorders containing same,dna encoding the proteins,and therapeutic agents in gene therapy for glycoprotein aberration disorders |
| 06/07/2001 | CA2393527A1 Educational kit and method using tumor necrosis factor-stimulated gene and protein |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2393233A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392941A1 Drug inducible system and use thereof |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392537A1 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/06/2001 | EP1104813A1 Conditional replication of recombinant human adenovirus DNA carrying modified inverted terminal repeat sequences |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104466A1 Leptin-related peptides |
| 06/06/2001 | EP1104463A1 Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependent kinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |